Results 171 to 180 of about 28,197 (214)

The emerging NDM carbapenemases

open access: yesTrends in Microbiology, 2011
Carbapenems were the last β-lactams retaining near-universal anti-Gram-negative activity, but carbapenemases are spreading, conferring resistance. New Delhi metallo-β-lactamase (NDM) enzymes are the latest carbapenemases to be recognized and since 2008 have been reported worldwide, mostly in bacteria from patients epidemiologically linked to the Indian
Nordmann, Patrice   +3 more
openaire   +6 more sources

Prevalence and Molecular Characterisation of New Delhi Metallo-β-Lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in Multidrug-Resistant Enterobacteriaceae From India

International Journal of Antimicrobial Agents, 2014
The growing prevalence of carbapenem resistance in Enterobacteriaceae worldwide is a major concern. New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance has been identified in Enterobacteriaceae from numerous countries including those of the Indian subcontinent. Currently, seven NDM β-lactamase variants (NDM-1 to -7) have been identified.
Avinash Singh   +2 more
exaly   +3 more sources

Dissemination of NDM-1

The Lancet Infectious Diseases, 2012
The dissemination of members of the Enterobacteriaceae family with extended spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) has become a global concern. ESBLs and MBLs have been reported in humans, domestic animals, wildlife and the environment, and their isolation frequencies are increasing rapidly worldwide. Most studies have been
Badrul, Hasan   +4 more
  +7 more sources

Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem Against NDM-1-Positive Enterobacteriaceae in Vitro

open access: yesInternational Journal of Environmental Research and Public Health, 2020
NDM-1-positive Enterobacteriaceae have caused serious clinical infections, with high mortality rates. Carbapenem was the ultimate expectation for the treatment of such infections in clinical practice.
Xuming Deng, Jianfeng Wang, Dacheng Wang
exaly   +2 more sources

Deciphering the Role of V88L Substitution in NDM-24 Metallo-β-Lactamase [PDF]

open access: yesCatalysts, 2019
The New Delhi metallo-β-lactamase-1 (NDM-1) is a typical carbapenemase and plays a crucial role in antibiotic-resistance bacterial infection. Phylogenetic analysis, performed on known NDM-variants, classified NDM enzymes in seven clusters.
Zhihai Liu, Yang Wang, Jianzhong Shen
exaly   +2 more sources

The directed evolution of NDM-1

Antimicrobial Agents and Chemotherapy, 2023
ABSTRACT β-Lactam antibiotics are among the most frequently prescribed therapeutic agents. A common mechanism of resistance toward β-lactam antibiotics is the production of β-lactamases. These enzymes are capable of hydrolyzing the β-lactam bond, rendering the drug inactive.
Caitlyn A. Thomas   +8 more
openaire   +2 more sources

Molecular Diversity of NDM-1, NDM-5, NDM-6, and NDM-7 Variants of New Delhi Metallo-β-Lactamases and Their Impact on Drug Resistance

Clinical Laboratory, 2021
The emergence of multidrug-resistant bacteria has become a serious healthcare problem worldwide.In this study, 192 clinical specimens collected from a tertiary hospital in Al Jouf, Saudi Arabia were processed in order to isolate gram-negative bacteria.
openaire   +2 more sources

Recent research and development of NDM-1 inhibitors

European Journal of Medicinal Chemistry, 2021
Bacteria carrying New Delhi metallo-β-lactamase-1 (New Delhi metallo-β-lactamase, NDM-1) resistance gene is a new type of "superbug", which can hydrolyze almost all β-lactam antibiotics, rapidly spread among the same species and even spread among different species. NDM-1 belongs to the class B1 broad-spectrum enzyme of β-lactamase.
Ting, Wang   +5 more
openaire   +2 more sources

Balkan NDM-1: escape or transplant?

The Lancet Infectious Diseases, 2011
164 www.thelancet.com/infection Vol 11 March 2011 4 Sadetzki S, Chetrit A, Lubina A, et al. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91: 4798–04. 5 Boaventura P, Bastos J, Pereira D, et al.
Livermore, David M.   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy